Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish

Federal Reserve interest rate policy to again remain the market focus this year and create a chaotic first half. Biotechnology should be favorably positioned relative to the market if the economy slips into a recession. Biotech fortunes near term are to be determined by the performance of the 10-year yield, which should likely remain anchored or slip due to economic concerns.

1 2 3 32